Directly observed therapy and risk of unfavourable tuberculosis treatment outcomes among an international cohort of people living with HIV in low- and middle-income countries

Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA./ Vanderbilt Tuberculosis Center, Nashville, TN, USA.
Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
College of Public Health, The Ohio State University, Columbus, OH, USA.
Academic Model Providing Access To Healthcare (AMPATH), Eldoret, Kenya.
Bach Mai Hospital, Hanoi, Vietnam.
TREAT Asia/amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Centre Intégré de Recherches Biocliniques d'Abidjan CIRBA, Abidjan, Côte d'Ivoire.
Centre INSERM U1219, Bordeaux Population Health, University of Bordeaux, Bordeaux, France.
Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA./ Vanderbilt Tuberculosis Center, Nashville, TN, USA.

Resumen en ingles

Identification of persons living with human immunodeficiency virus (HIV)-associated tuberculosis (TB) at increased risk for unfavourable TB outcomes would inform efforts to improve such outcomes. We sought to identify factors associated with a decreased risk of unfavourable TB treatment outcomes among people living with HIV-infection (PLHIV) in low- and middle-income countries (LMIC), with a specific focus on directly observed therapy (DOT) compared with self-administered therapy (SAT) during the continuation phase of anti-TB therapy.

Palabras clave en ingles

Antiretroviral therapy
Body mass index
Directly observed therapy
Human immunodeficiency virus infection
Tuberculosis

Editor

Wiley

Referencia

PETTIT, April C. et al. Directly observed therapy and risk of unfavourable tuberculosis treatment outcomes among an international cohort of people living with HIV in low- and middle-income countries. Journal of the International AIDS Society, v. 22, n. 12, p. e25423, 2019.

DOI

10.1002/jia2.25423

ISSN

1758-2652

Notas

The International Epidemiology Databases to Evaluate AIDS (IeDEA) Collaboration is an international research consortium established in 2006 by the National Institute of Allergy and Infectious Diseases to provide a rich resource for globally diverse HIV/AIDS data.

Por favor, use este identificador para citar o enlazar este ítem: https://www.arca.fiocruz.br/handle/icict/38792

Tipo

Derechos de autor

Acceso abierto

Colecciones

Compartir

Estadísticas

Metadatos

Autor

Afiliación